(0.29%) 5 114.61 points
(0.30%) 38 354 points
(0.31%) 15 977 points
(-0.93%) $83.07
(5.67%) $2.03
(0.37%) $2 356.00
(0.45%) $27.66
(3.99%) $958.90
(-0.21%) $0.933
(-0.37%) $10.98
(-0.54%) $0.796
(1.69%) $93.43
Live Chart Being Loaded With Signals
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally...
Stats | |
---|---|
本日の出来高 | 9 279.00 |
平均出来高 | 39 716.00 |
時価総額 | 265.65M |
EPS | €0 ( 2024-03-27 ) |
次の収益日 | ( €-0.0800 ) 2024-05-15 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -11.74 |
ATR14 | €0.0560 (0.78%) |
Edap Tms SA 相関
10 最も負の相関 | |
---|---|
DAKT | -0.924 |
BOTZ | -0.919 |
HGBL | -0.918 |
AMD | -0.918 |
QQQ | -0.917 |
QQQM | -0.917 |
LMB | -0.916 |
QYLG | -0.915 |
TQQQ | -0.913 |
GOOGL | -0.903 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Edap Tms SA 財務諸表
Annual | 2023 |
収益: | €59.18M |
総利益: | €23.91M (40.40 %) |
EPS: | €-0.560 |
FY | 2023 |
収益: | €59.18M |
総利益: | €23.91M (40.40 %) |
EPS: | €-0.560 |
FY | 2022 |
収益: | €55.11M |
総利益: | €24.19M (43.90 %) |
EPS: | €-0.0853 |
FY | 2021 |
収益: | €44.07M |
総利益: | €18.42M (41.81 %) |
EPS: | €0.0200 |
Financial Reports:
No articles found.
Edap Tms SA
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。